Article Versions Notes

Topf A, Mirna M, Dienhart C, Jirak P, Bacher N, Boxhammer E, Gharibeh SX, Motloch LJ, Hoppe UC, Lichtenauer M. Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome. Biomedicines. 2022; 10(2):464. https://doi.org/10.3390/biomedicines10020464

Topf, Albert, Moritz Mirna, Christiane Dienhart, Peter Jirak, Nina Bacher, Elke Boxhammer, Sarah X. Gharibeh, Lukas J. Motloch, Uta C. Hoppe, and Michael Lichtenauer. 2022. "Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome" Biomedicines 10, no. 2: 464. https://doi.org/10.3390/biomedicines10020464

Topf, A., Mirna, M., Dienhart, C., Jirak, P., Bacher, N., Boxhammer, E., Gharibeh, S. X., Motloch, L. J., Hoppe, U. C., & Lichtenauer, M. (2022). Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome. Biomedicines, 10(2), 464. https://doi.org/10.3390/biomedicines10020464